Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis—implications for surveillance and future pharmacotherapy
Open Access
- 1 April 2020
- journal article
- editorial
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 9 (2) , 230-234
Abstract
Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis—implications for surveillance and future pharmacotherapyKeywords
This publication has 22 references indexed in Scilit:
- Multi-drug approaches to NASH: what’s in the development pipeline?Expert Opinion on Investigational Drugs, 2019
- Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver DiseaseHepatology, 2019
- Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseasesAlimentary Pharmacology & Therapeutics, 2018
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- Underreporting of Liver Transplant Waitlist Removals Due to Death or Clinical DeteriorationTransplantation, 2013
- An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese miceGut, 2013
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology, 2013
- Gut microbiota-derived propionate reduces cancer cell proliferation in the liverBritish Journal of Cancer, 2012
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosisHepatology, 2009
- The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic EvidenceClinical Gastroenterology and Hepatology, 2006